Tivic Health Systems, Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19
	10-K	10-K	10-K	S-1/A
Revenues	1.8	1.3	0.9	0.4
Revenue growth	46.4%	46.2%	104.8%
Cost of goods sold	1.5	1.3	1.1	0.7
Gross profit	0.3	0.0	-0.2	-0.3
Gross margin	16.3%	-3.0%	-26.2%	-68.8%
Selling, general and administrative [+]	8.7	4.7	2.3	2.4
Sales and marketing	2.8	1.8	1.3	1.2
General and administrative	5.9	2.9	1.0	1.2
Research and development	1.7	0.9
Other operating expenses		0.4	0.7	1.0
EBITDA [+]	-10.1	-6.1	-3.2	-3.6
EBITDA growth	66.4%	89.6%	-12.2%
EBITDA margin	-548.3%	-482.2%	-371.6%	-866.4%
Depreciation and amortization	0.0	0.0	0.0	0.0
EBIT [+]	-10.1	-6.1	-3.2	-3.6
EBIT growth	66.4%	89.4%	-12.1%
EBIT margin	-548.8%	-482.8%	-372.6%	-867.4%
Non-recurring items		-0.4
Interest expense, net [+]	0.0	1.8	0.4	0.4
Interest expense		1.8	0.4	0.4
Interest income	0.0
Other income (expense), net [+]		-1.0	0.0	-0.1
Gain (loss) on debt retirement		-1.6
Gain (loss) on derivative instruments		0.4
Other non-operating income		0.2
Other		0.2	0.0	0.0
Pre-tax income	-10.1	-8.5	-3.6	-4.1
Income taxes	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	-10.1	-8.5	0.0	0.0
Net margin	-548.7%	-675.7%	0.0%	0.0%

Basic EPS [+]	($1.04)	($2.43)	$0.00	$0.00
Growth	-57.1%
Diluted EPS [+]	($1.04)	($2.43)	$0.00	$0.00
Growth	-57.1%

Shares outstanding (basic) [+]	9.7	3.5	2,303.2	2,300.0
Growth	176.9%	-99.8%	0.1%
Shares outstanding (diluted) [+]	9.7	3.5	2,303.2	2,300.0
Growth	176.9%	-99.8%	0.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.